BEBE
US • —
$315.66
P/E
14373.07
PEG
—
FCF Yield
—
Rev Growth YoY
+56.5% YoY
Gross Margin
29.6%
Health Score
3/10
D/E Ratio
3.73
Confidence
LOW
Business Snapshot
This company operates in a sector with limited publicly available financial detail. The defining financial characteristic is a price-to-sales ratio of 35.41x, a debt-to-equity ratio of 3.73x, and a current ratio of 5.98x. Revenue grew 56.5% year-over-year, indicating a high-growth phase, while net margin stands at a thin 0.2%. The business is capitalised with a market cap tier that could not be determined from the available data, and its competitive position relative to peers cannot be assessed from the provided metrics.
Financial Health
The company reports a gross margin of 29.6% and a thin net margin of 0.2%, indicating that a significant portion of revenue is consumed by operating or non-operating costs. The balance sheet shows a high debt-to-equity ratio of 3.73x, suggesting a leveraged capital structure that could strain finances in a downturn, although the current ratio of 5.98x indicates ample short-term liquidity to cover near-term obligations...
Risk Assessment
- VALUATION — P/E ratio of 14373.07x is extreme and far above the sector average of 22x, suggesting earnings are near zero or temporarily depressed.
- EARNINGS QUALITY — Out of 4 recent quarters, the company beat estimates in all 4 quarters, which is generally positive but provides limited context given the lack of reported earnings figures.
- DEBT / LIQUIDITY — Debt-to-equity of 3.73x indicates a highly leveraged capital structure, posing financial risk if business conditions worsen.
- TECHNICALS — RSI, MACD, and moving average data unavailable for this period; momentum cannot be independently confirmed.
- PROFITABILITY — Net margin of 0.2% is extremely thin, leaving little room for error and limited earnings power....
The company reports a gross margin of 29.6% and a thin net margin of 0.2%, indicating that a significant portion of revenue is consumed by operating or non-operating costs. The balance sheet shows a high debt-to-equity ratio of 3.73x, suggesting a leveraged capital structure that could strain finances in a downturn, although the current ratio of 5.98x indicates ample short-term liquidity to cover near-term obligations. Return on equity is a minimal 0.8%, reflecting poor profitability relative to shareholder equity. Free cash flow data was not available in the payload, preventing a cash generation assessment. Overall, the company’s financial health is weak due to razor-thin margins and high leverage, limiting its capacity for internal reinvestment and increasing its vulnerability to economic shocks.
- VALUATION — P/E ratio of 14373.07x is extreme and far above the sector average of 22x, suggesting earnings are near zero or temporarily depressed. - EARNINGS QUALITY — Out of 4 recent quarters, the company beat estimates in all 4 quarters, which is generally positive but provides limited context given the lack of reported earnings figures. - DEBT / LIQUIDITY — Debt-to-equity of 3.73x indicates a highly leveraged capital structure, posing financial risk if business conditions worsen. - TECHNICALS — RSI, MACD, and moving average data unavailable for this period; momentum cannot be independently confirmed. - PROFITABILITY — Net margin of 0.2% is extremely thin, leaving little room for error and limited earnings power.
Unlock the full AI report
Full 8-section analysis includes:
Metric deep-dives